CLOMIPRAMINE INCREASES THE RESPONSIVENESS OF RAPHE-CORTICAL NEURONS IN THE RAT

被引:5
作者
CONTRERAS, CM
MARVAN, ML
MUNOZMENDEZ, A
机构
[1] UNIV VERACRUZ, INST INVEST BIOMED, DEPT FISIOL, NEUROPHARMACOL, JALAPA, MEXICO
[2] UNIV VERACRUZ, INST NEUROETOL, JALAPA, MEXICO
关键词
CLOMIPRAMINE; SEROTONIN; SEROTONIN RECEPTORS; TRICYCLIC; RAPHE NUCLEI; CEREBRAL CORTEX;
D O I
10.1159/000118981
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The cerebral cortex of the rat possesses 5-HT1A receptor subtype; however, whether the activation of this receptor by dorsal raphe nucleus stimulation produces a similar action on neuronal cortical firing as antidepressants acting on serotonin (5-HT) function is unknown. Single-unit extracellular recordings were obtained from parietal cortex in rats in which dorsal raphe nucleus or cerebellar peduncle was stimulated. Results compared groups long-term treated with clomipramine (1.25 mg/kg i.p., twice a day, during 30 days) or saline (0.15 ml i.p., twice a day, during 30 days). Amplitude of traces, firing rate, and response to treatment with clomipramine proved to be different between cortical neurons responding to dorsal raphe nucleus or cerebellar peduncle stimulation. Clomipramine increased a long-lasting cortical suppression of firing elicited by dorsal raphe nucleus stimulation. Obtained data suggests that the responses of nearby cortical neurons containing different kinds of 5-HT receptors may relate to the involved pathways and that clomipramine seems to act on 5-HT1A receptor subtype.
引用
收藏
页码:199 / 203
页数:5
相关论文
共 25 条
[1]  
ADELL A, 1991, N-S ARCH PHARMACOL, V343, P237
[2]   CHRONIC ADMINISTRATION OF CLOMIPRAMINE PREVENTS THE INCREASE IN SEROTONIN AND NORADRENALINE INDUCED BY CHRONIC STRESS [J].
ADELL, A ;
GARCIAMARQUEZ, C ;
ARMARIO, A ;
GELPI, E .
PSYCHOPHARMACOLOGY, 1989, 99 (01) :22-26
[3]  
BLIER P, 1988, CLIN NEUROPHARMACOL, V11, pS1
[4]  
CHAPUT Y, 1988, J PHARMACOL EXP THER, V246, P359
[5]  
CONTRERAS C M, 1991, Boletin de Estudios Medicos y Biologicos Universidad Nacional Autonoma de Mexico, V39, P3
[6]  
DEMONTIGNY C, 1988, NEW CONCEPTS DEPRESS, P144
[7]  
GOLDFARB J, 1990, NEUROPSYCHOPHARMACOL, V3, P435
[8]   EFFECTS OF ANTI-DEPRESSANT DRUGS ON DIFFERENT RECEPTORS IN THE BRAIN [J].
HALL, H ;
OGREN, SO .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1981, 70 (03) :393-407
[9]  
HENSLER JG, 1991, NEUROPSYCHOPHARMACOL, V4, P131
[10]  
JACOBS BL, 1990, NEUROPSYCHOPHARMACOL, V3, P473